1. Home
  2. PLSE vs VERA Comparison

PLSE vs VERA Comparison

Compare PLSE & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$51.63

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$32.68

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
VERA
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PLSE
VERA
Price
$51.63
$32.68
Analyst Decision
Buy
Strong Buy
Analyst Count
1
10
Target Price
$22.00
★ $81.30
AVG Volume (30 Days)
612.2K
★ 2.3M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$840.00
N/A
Revenue Next Year
$287.54
$472.48
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$23.05
52 Week High
$58.90
$56.05

Technical Indicators

Market Signals
Indicator
PLSE
VERA
Relative Strength Index (RSI) 54.39 45.60
Support Level $49.01 $30.05
Resistance Level $58.90 $33.09
Average True Range (ATR) 4.59 2.17
MACD -0.70 -0.13
Stochastic Oscillator 35.18 25.21

Price Performance

Historical Comparison
PLSE
VERA

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: